HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jean-Olivier Durand Selected Research

Lectins

5/2015Mannose-6-phosphate receptor: a target for theranostics of prostate cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jean-Olivier Durand Research Topics

Disease

34Neoplasms (Cancer)
10/2023 - 07/2010
15Breast Neoplasms (Breast Cancer)
06/2023 - 03/2009
4Prostatic Neoplasms (Prostate Cancer)
07/2023 - 05/2015
2Phototoxic Dermatitis (Phototoxicity)
09/2019 - 12/2010
2Retinoblastoma (Glioblastoma, Retinal)
01/2018 - 08/2012
2Colorectal Neoplasms (Colorectal Cancer)
09/2012 - 02/2012
1Rhabdomyosarcoma
07/2020
1Hyperthermia
01/2019
1Alzheimer Disease (Alzheimer's Disease)
11/2018
1Atherosclerosis
11/2018
1Skin Neoplasms (Skin Cancer)
01/2018
1Ovarian Neoplasms (Ovarian Cancer)
01/2018
1Inflammation (Inflammations)
09/2017
1Lymphoma (Lymphomas)
05/2013
1Neuroblastoma
05/2013
1Glioblastoma (Glioblastoma Multiforme)
05/2013
1Rare Diseases (Rare Disease)
08/2012

Drug/Important Bio-Agent (IBA)

141-phenyl-3,3-dimethyltriazene (PDT)IBA
06/2023 - 03/2009
11Silicon Dioxide (Silica)FDA LinkGeneric
06/2019 - 07/2010
9Mannose (D-Mannose)IBA
07/2020 - 03/2009
7Small Interfering RNA (siRNA)IBA
10/2023 - 09/2019
6SiliconIBA
10/2023 - 05/2013
5Doxorubicin (Adriamycin)FDA LinkGeneric
07/2023 - 09/2014
5PorphyrinsIBA
01/2023 - 05/2013
4LuciferasesIBA
01/2023 - 09/2019
4CamptothecinIBA
12/2013 - 02/2012
3Photosensitizing Agents (Photosensitizers)IBA
07/2023 - 02/2012
2Proteins (Proteins, Gene)FDA Link
10/2023 - 07/2023
2Singlet OxygenIBA
07/2023 - 01/2018
2Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric
12/2022 - 02/2016
2AT 760IBA
09/2019 - 09/2016
2CationsIBA
06/2019 - 05/2015
2GoldIBA
01/2016 - 01/2015
14,4- difluoro- 4- bora- 3a,4a- diaza- s- indacene (BODIPY)IBA
01/2023
1ethyleneIBA
12/2022
1diazonaphthalenedisulfonic acid (NDS)IBA
12/2022
1Polymethyl Methacrylate (Sol)IBA
12/2022
1PolymersIBA
07/2020
1EthaneIBA
11/2019
1Peptide Hydrolases (Proteases)FDA Link
01/2019
1pepstatin (pepstatin A)IBA
01/2019
1Cathepsin DIBA
01/2019
1Peptides (Polypeptides)IBA
01/2019
1Nanoparticle Drug Delivery SystemIBA
01/2018
1LipopolysaccharidesIBA
09/2017
1Diclofenac (SR 38)FDA LinkGeneric
09/2017
1mannose-6-phosphateIBA
06/2016
1RutheniumIBA
02/2016
1LigandsIBA
02/2016
1DisulfidesIBA
08/2015
1LectinsIBA
05/2015
1IGF Type 2 Receptor (Insulin-Like-Growth-Factor II Receptor)IBA
05/2015
1Mannose ReceptorIBA
12/2014
1Rituximab (Mabthera)FDA Link
05/2013
1AntibodiesIBA
05/2013
1Hyaluronic Acid (Hyaluronan)IBA
09/2012
1CarbohydratesIBA
08/2012
1Galactose (Galactopyranose)FDA LinkGeneric
02/2012
1galactose receptorIBA
02/2012

Therapy/Procedure

16Photochemotherapy (Photodynamic Therapy)
06/2023 - 07/2010
13Therapeutics
06/2023 - 02/2012
7Precision Medicine
12/2022 - 05/2015
2Lasers (Laser)
10/2019 - 09/2016
1Drug Therapy (Chemotherapy)
07/2023
1Nanospheres
01/2016